The number dazzles — the fine print complicates it.
The India EMS market just earned a headline-grabbing forecast — $150 billion by FY30 — but the same KPMG India report that produced that figure also flagged a structural weakness investors cannot afford to overlook. Released on 8 June 2026, the study estimates the sector has expanded from roughly $10–12 billion in FY20 to $40–45 billion in FY25, powered by domestic demand, policy incentives, and China-plus-one sourcing shifts. Reaching $150 billion in five more years implies a compounded annual growth rate close to 29 per cent — a demanding pace for an industry where margins remain paper-thin.
The core tension is what KPMG calls a “scale without depth” paradox. India dominates high-volume assembly, particularly in smartphones and consumer electronics, yet its footprint in higher-value segments — component design, intellectual-property ownership, and advanced manufacturing — stays limited. Import dependency on critical parts still runs between 80 and 95 per cent, which means the India EMS market’s revenue growth has consistently outpaced its ability to capture value from every unit shipped. In dollar terms, four-fifths or more of each assembled product’s component cost flows abroad.
The global picture sharpens the challenge. The worldwide EMS industry is valued at roughly $640–650 billion today and could exceed $1 trillion by the early 2030s. India’s present share of 5–6 per cent would need to nearly triple — to around 15 per cent — if the domestic target is to materialise against that expanding base. Cumulative policy incentives totalling approximately $19.5 billion have fuelled the climb so far, but KPMG cautioned that the next phase demands far deeper investment in component ecosystems, engineering capability, and supply-chain sophistication beyond assembly.
For shareholders in listed India EMS market leaders on the BSE — Dixon Technologies, Kaynes Technology, Syrma SGS, and Amber Enterprises — that tension is already partly reflected in prices. Several of these stocks corrected 30–50 per cent from their peaks over recent quarters, and brokerage opinion remains split between those citing a multi-year upcycle and those flagging near-term margin pressure from input costs and expiring smartphone PLI benefits. Two items worth tracking in the quarters ahead: progress on the government’s Electronic Component Manufacturing Scheme earmarked at ₹40,000 crore, and whether fresh PLI extensions can nudge the India EMS market’s value chain from assembly toward genuine component localisation.
This article is journalism and educational commentary, not investment advice. The author is not a SEBI-registered Research Analyst. Figures should be independently verified against official filings before any financial decision.
Found this useful? Forward it to a fellow investor who tracks India’s manufacturing story.
